# Can VI-RADS/ADC Accurately Stage Bladder Cancer??

> **NCT04167631** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Mansoura University** · enrollment: 150 (estimated)

## Conditions studied

- MRI Contrast Media Adverse Reaction
- Bladder Cancer
- Bladder Disease
- Bladder Neoplasm
- Bladder Urothelial Carcinoma
- Bladder Cancer Stage
- Diagnoses Disease

## Interventions

- **RADIATION:** Multi-parametric MRI

## Key facts

- **NCT ID:** NCT04167631
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-01-01
- **Primary completion:** 2024-12-01
- **Final completion:** 2024-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04167631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04167631, "Can VI-RADS/ADC Accurately Stage Bladder Cancer??". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04167631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*